"Is Intravenous Immunoglobulin Therapy for Chronic Pain Conditions an Underused Treatment Option?" by Nirguna Thalla, MD, MBA, Resident, MedStar Georgetown University, Washington, DC; Keith Newton, MD, Resident, University of Central Florida College of Medicine, Orlando, Florida; and Dalia Elmofty, MD, Associate Professor, University of Chicago Medicine, Chicago, Illinois. From ASRA Pain Medicine News, February 2022. See original article at www.asra.com/asra-news for figures and references. This material is copyrighted.   <a rel="payment" href="https://www.asra.com/about-asra/donate">Support the show</a>

ASRA News

Is Intravenous Immunoglobulin Therapy for Chronic Pain Conditions an Underused Treatment Option?

ASRA News is the official newsletter of the American Society of Regional Anesthesia and Pain Medicine (ASRA). Published quarterly online (www.asra.com/asra-news) in February, May, August, and November, newsletter articles address hot topics in the field and provide an opportunity for regional anesthesiology and pain medicine physicians and healthcare providers to share their experiences and recommendations for various aspects of practice. The publication also includes organization news, updates, and meeting information. Note: Mention of specific products do not indicate or imply endorsement. Author opinions do not necessarily represent those of ASRA.